Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection

Infect Immun. 2023 Apr 18;91(4):e0016922. doi: 10.1128/iai.00169-22. Epub 2023 Mar 20.

Abstract

Bacterial flagella are involved in infection through their roles in host cell adhesion, cell invasion, auto-agglutination, colonization, the formation of biofilms, and the regulation and secretion of nonflagellar bacterial proteins that are involved in the virulence process. In this study, we constructed a fusion protein vaccine (FliCD) containing the Clostridioides difficile flagellar proteins FliC and FliD. The immunization of mice with FliCD induced potent IgG and IgA antibody responses against FliCD, protected mice against C. difficile infection (CDI), and decreased the C. difficile spore and toxin levels in the feces after infection. Additionally, the anti-FliCD serum inhibited the binding of C. difficile vegetative cells to HCT8 cells. These results suggest that FliCD may represent an effective vaccine candidate against CDI.

Keywords: Clostridioides difficile infection (CDI); FliCD; chimeric protein vaccine; hyperimmune serum.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Proteins / metabolism
  • Bacterial Vaccines / genetics
  • Clostridioides / metabolism
  • Clostridioides difficile*
  • Clostridium Infections* / microbiology
  • Mice
  • Recombinant Fusion Proteins / genetics

Substances

  • Recombinant Fusion Proteins
  • Bacterial Proteins
  • Bacterial Vaccines